Although the advent and use of prostate specific antigen (PSA) as “marker’ and a screening tool of diseases progression has aided the early detection of prostate cancer, its shortfall remains the lack of robustness in discriminating indolent from aggressive disease [4, 10, 11]. Here, KLK3 is linked to prostate carcinoma.